• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病性精神病:临床特征与病史

Psychosis of Alzheimer's disease: clinical characteristics and history.

作者信息

Schneider Lon S, Dagerman Karen S

机构信息

Department of Psychiatry and the Behavioral Sciences, University of Southern California, Keck School of Medicine, 1975 Zonal Avenue, KAM 400, Los Angeles, CA 90033, USA.

出版信息

J Psychiatr Res. 2004 Jan;38(1):105-11. doi: 10.1016/s0022-3956(03)00092-x.

DOI:10.1016/s0022-3956(03)00092-x
PMID:14690773
Abstract

The concept of psychosis of Alzheimer's disease and dementia is developed with respect to prevalence, incidence, clinical characteristics, clinical course, and potential response to treatment. Psychosis frequently occurs subsequent to the onset of dementia. Published prevalence estimates of psychosis in patients with AD range from 10 to 73% with an overall median of 34% within clinic populations, and from 7 to 20% in community and clinical trials populations depending on definitions used. Among people with AD who have no psychotic symptoms there appears to be an annualized incidence of psychosis of about 20% in outpatients, and a much higher rate in nursing home patients. Female gender, somewhat greater cognitive impairment among outpatients, somewhat lesser cognitive impairment among nursing home patients, and physical aggression are more associated with psychotic signs and symptoms than not. Right frontal hypometabolism and greater frontal neuropsychological deficits occur in AD patients with psychosis in comparison to those without. Among nursing home patients with dementia who have clinically significant agitation, the substantial majority have delusions or hallucinations. Among patients in nursing homes with dementia and psychosis, nearly two-thirds have persistent symptoms over at least 12 weeks, and among outpatient studies, hallucinations and delusions may persist in approximately 40-50% over periods of 3 months to one year. There is some evidence that psychotic symptoms improve modestly with antipsychotic medication treatment. There is sufficient descriptive and empirical research to support the validity of a syndrome of psychosis of Alzheimer's disease.

摘要

阿尔茨海默病和痴呆症的精神病概念是根据患病率、发病率、临床特征、临床病程以及对治疗的潜在反应来阐述的。精神病常在痴呆症发病后出现。已发表的关于阿尔茨海默病患者精神病患病率的估计值在10%至73%之间,在临床人群中总体中位数为34%,在社区和临床试验人群中为7%至20%,具体数值取决于所采用的定义。在没有精神病症状的阿尔茨海默病患者中,门诊患者的精神病年化发病率约为20%,而在养老院患者中发病率要高得多。女性、门诊患者中认知障碍稍重、养老院患者中认知障碍稍轻以及身体攻击行为与精神病体征和症状的关联度更高。与无精神病的阿尔茨海默病患者相比,有精神病的患者右侧额叶代谢减退且额叶神经心理学缺陷更明显。在临床上有明显激越症状的痴呆养老院患者中,绝大多数有妄想或幻觉。在患有痴呆症和精神病的养老院患者中,近三分之二的患者至少12周内症状持续存在,在门诊研究中,幻觉和妄想在3个月至1年的时间里可能在约40% - 50%的患者中持续存在。有一些证据表明,抗精神病药物治疗可使精神病症状略有改善。有足够的描述性和实证研究支持阿尔茨海默病精神病综合征的有效性。

相似文献

1
Psychosis of Alzheimer's disease: clinical characteristics and history.阿尔茨海默病性精神病:临床特征与病史
J Psychiatr Res. 2004 Jan;38(1):105-11. doi: 10.1016/s0022-3956(03)00092-x.
2
Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.与痴呆相关的激越、攻击行为和精神病的管理:一项汇总分析,包括三项在接受利培酮治疗的疗养院居民中进行的随机、安慰剂对照双盲试验。
Clin Neurol Neurosurg. 2005 Oct;107(6):497-508. doi: 10.1016/j.clineuro.2005.03.013.
3
The effects of olanzapine in reducing the emergence of psychosis among nursing home patients with Alzheimer's disease.奥氮平对降低患有阿尔茨海默病的疗养院患者精神病发作风险的影响。
J Clin Psychiatry. 2001 Jan;62(1):34-40. doi: 10.4088/jcp.v62n0108.
4
Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003.阿尔茨海默病性精神病的流行病学及危险因素:对1990年至2003年发表的55项研究的综述
Am J Psychiatry. 2005 Nov;162(11):2022-30. doi: 10.1176/appi.ajp.162.11.2022.
5
The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease.可能患有阿尔茨海默病的患者中,常规和非典型抗精神病药物的长期影响。
Am J Psychiatry. 2013 Sep;170(9):1051-8. doi: 10.1176/appi.ajp.2013.12081046.
6
The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.利培酮治疗阿尔茨海默病和混合性痴呆所致精神病的疗效和安全性:4项安慰剂对照临床试验的荟萃分析。
Int J Geriatr Psychiatry. 2007 May;22(5):475-84. doi: 10.1002/gps.1792.
7
Psychosis associated behavioral and psychological signs and symptoms in mild cognitive impairment and Alzheimer's dementia.轻度认知障碍和阿尔茨海默病性痴呆中与精神病相关的行为和心理症状及体征
Aging Ment Health. 2015;19(9):818-28. doi: 10.1080/13607863.2014.967170. Epub 2014 Oct 17.
8
Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial.利培酮治疗阿尔茨海默病和混合性痴呆的精神病症状:一项双盲、安慰剂对照试验的结果。
Int J Geriatr Psychiatry. 2005 Dec;20(12):1153-7. doi: 10.1002/gps.1409.
9
How to manage depression and psychosis in Alzheimer's disease.如何管理阿尔茨海默病中的抑郁和精神病症状。
Geriatrics. 1995 Jan;50(1):43-6, 49.
10
Atypical antipsychotics for the treatment of dementia-related behaviors: an update.用于治疗痴呆相关行为的非典型抗精神病药物:最新进展
Med Health R I. 2007 Jun;90(6):191-4.

引用本文的文献

1
Psychotic Symptoms in Patients With Major Neurological Diseases.患有主要神经系统疾病患者的精神病症状
J Clin Neurol. 2024 Mar;20(2):153-165. doi: 10.3988/jcn.2023.0501.
2
Searching for new drugs for the treatment of dementia-related psychosis.寻找用于治疗痴呆相关精神病的新药。
Postep Psychiatr Neurol. 2021 Dec;30(4):270-277. doi: 10.5114/ppn.2021.111942. Epub 2021 Dec 21.
3
Psychotic disorders in late life: a narrative review.老年期精神病性障碍:一项叙述性综述。
Ther Adv Psychopharmacol. 2019 Oct 16;9:2045125319882798. doi: 10.1177/2045125319882798. eCollection 2019.
4
Factors associated with the onset of Alzheimer's disease: Data mining in the French nationwide discharge summary database between 2008 and 2014.与阿尔茨海默病发病相关的因素:2008 年至 2014 年法国全国出院记录数据库中的数据挖掘。
PLoS One. 2019 Jul 25;14(7):e0220174. doi: 10.1371/journal.pone.0220174. eCollection 2019.
5
Neuroprotection by aripiprazole against β-amyloid-induced toxicity by P-CK2α activation via inhibition of GSK-3β.阿立哌唑通过抑制糖原合成酶激酶-3β激活P-CK2α对β-淀粉样蛋白诱导的毒性发挥神经保护作用。
Oncotarget. 2017 Nov 30;8(66):110380-110391. doi: 10.18632/oncotarget.22777. eCollection 2017 Dec 15.
6
Optimal treatment of Alzheimer's disease psychosis: challenges and solutions.阿尔茨海默病性精神病的最佳治疗:挑战与对策。
Neuropsychiatr Dis Treat. 2014 Nov 24;10:2253-62. doi: 10.2147/NDT.S60837. eCollection 2014.
7
Psychotic Alzheimer's disease is associated with gender-specific tau phosphorylation abnormalities.患有精神病症状的阿尔茨海默病与特定性别的tau蛋白磷酸化异常有关。
Neurobiol Aging. 2014 Sep;35(9):2021-8. doi: 10.1016/j.neurobiolaging.2014.03.003. Epub 2014 Mar 6.
8
Understanding egorrhea from cultural-clinical psychology.从文化临床心理学理解恋粪癖。
Front Psychol. 2013 Nov 28;4:894. doi: 10.3389/fpsyg.2013.00894. eCollection 2013.
9
Neuropsychiatric symptoms and regional neocortical atrophy in mild cognitive impairment and Alzheimer's disease.轻度认知障碍和阿尔茨海默病的神经精神症状与区域性大脑皮质萎缩。
Am J Alzheimers Dis Other Demen. 2014 Mar;29(2):159-65. doi: 10.1177/1533317513507373. Epub 2013 Oct 27.
10
Impact of behavioral subsyndromes on cognitive decline in Alzheimer's disease: data from the ICTUS study.行为亚综合征对阿尔茨海默病认知衰退的影响:来自 ICTUS 研究的数据。
J Neurol. 2013 Jul;260(7):1859-65. doi: 10.1007/s00415-013-6893-3. Epub 2013 Mar 17.